Acutus Medical, Inc. (NASDAQ:AFIB – Get Free Report) was the target of a significant increase in short interest in the month of January. As of January 31st, there was short interest totalling 1,370,000 shares, an increase of 1,054.2% from the January 15th total of 118,700 shares. Approximately 7.3% of the company’s stock are sold short. Based on an average daily volume of 1,970,000 shares, the days-to-cover ratio is presently 0.7 days.
Acutus Medical Stock Up 6.2 %
Shares of Acutus Medical stock opened at $0.20 on Tuesday. Acutus Medical has a 52-week low of $0.16 and a 52-week high of $1.64. The company has a 50 day moving average of $0.20 and a 200 day moving average of $0.41. The company has a quick ratio of 3.85, a current ratio of 4.92 and a debt-to-equity ratio of 1.10. The company has a market capitalization of $5.80 million, a P/E ratio of -0.16 and a beta of 0.15.
Hedge Funds Weigh In On Acutus Medical
A number of institutional investors have recently modified their holdings of the business. Bank of Montreal Can purchased a new stake in shares of Acutus Medical in the 1st quarter worth about $34,000. Cerity Partners LLC purchased a new stake in shares of Acutus Medical in the 1st quarter worth about $48,000. Mirabella Financial Services LLP purchased a new stake in shares of Acutus Medical in the 1st quarter worth about $48,000. Schonfeld Strategic Advisors LLC boosted its position in shares of Acutus Medical by 1,065.1% in the 1st quarter. Schonfeld Strategic Advisors LLC now owns 170,100 shares of the company’s stock worth $128,000 after buying an additional 155,500 shares in the last quarter. Finally, AQR Capital Management LLC boosted its position in shares of Acutus Medical by 844.0% in the 2nd quarter. AQR Capital Management LLC now owns 174,352 shares of the company’s stock worth $195,000 after buying an additional 155,883 shares in the last quarter. 31.29% of the stock is owned by institutional investors and hedge funds.
About Acutus Medical
Acutus Medical, Inc, an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
- Five stocks we like better than Acutus Medical
- How to Invest in Small Cap Stocks
- 3 attractive stocks that insiders are buying
- Stock Dividend Cuts Happen Are You Ready?
- Alpha and Omega Semiconductor ready to bounce, DOJ cloud lifts
- How and Why to Invest in Oil Stocks
- Wendy’s vs Shake Shack: Out with the new, in with the old?
Receive News & Ratings for Acutus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acutus Medical and related companies with MarketBeat.com's FREE daily email newsletter.